{"id":"https://openalex.org/W1877987448","doi":null,"title":"Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells.","display_name":"Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells.","publication_year":2013,"publication_date":"2013-08-01","ids":{"openalex":"https://openalex.org/W1877987448","mag":"1877987448","pmid":"https://pubmed.ncbi.nlm.nih.gov/23898080"},"language":"en","primary_location":{"id":"pmid:23898080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23898080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082847049","display_name":"Micha\u0142 Wo\u017aniak","orcid":"https://orcid.org/0000-0003-2251-8647","observed_orcids":["https://orcid.org/0000-0003-2251-8647"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Michal Wozniak","raw_affiliation_strings":["Department of Molecular Biology of Cancer, Medical University of Lodz, 6/8 Mazowiecka Street; 92-215 Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology of Cancer, Medical University of Lodz, 6/8 Mazowiecka Street; 92-215 Lodz, Poland","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069448585","display_name":"Agata Szu\u0142awska\u2010Mroczek","orcid":"https://orcid.org/0000-0003-1231-6339","observed_orcids":["https://orcid.org/0000-0003-1231-6339"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agata Szulawska-Mroczek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055134443","display_name":"Mariusz L. Hartman","orcid":"https://orcid.org/0000-0002-2231-3740","observed_orcids":["https://orcid.org/0000-0002-2231-3740"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariusz L Hartman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045988492","display_name":"Dariusz Nejc","orcid":"https://orcid.org/0000-0002-7436-8831","observed_orcids":["https://orcid.org/0000-0002-7436-8831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dariusz Nejc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5001934449","display_name":"Ma\u0142gorzata Czy\u017c","orcid":"https://orcid.org/0000-0002-8279-4742","observed_orcids":["https://orcid.org/0000-0002-8279-4742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malgorzata Czyz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5559,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.59253195,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"33","issue":"8","first_page":"3205","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11547","display_name":"Sesquiterpenes and Asteraceae Studies","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11547","display_name":"Sesquiterpenes and Asteraceae Studies","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parthenolide","display_name":"parthenolide","score":0.9879999756813049},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6610000133514404},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9160000085830688},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.7749999761581421},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9980000257492065},{"id":"https://openalex.org/keywords/abcb5","display_name":"ABCB5","score":0.7749999761581421},{"id":"https://openalex.org/keywords/mmp-9","display_name":"MMP-9","score":0.6420000195503235},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6909999847412109},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2780321935","wikidata":"https://www.wikidata.org/wiki/Q2662393","display_name":"Parthenolide","level":3,"score":0.9674556255340576},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.718957781791687},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6833505630493164},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.5469220280647278},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5417104959487915},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.46737781167030334},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.454770565032959},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.4546757638454437},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4478845000267029},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.437500536441803},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4269479513168335},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4257362484931946},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39091742038726807},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3313755989074707},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15042120218276978},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14890509843826294},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.14528590440750122},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0713539719581604},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23898080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23898080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:1877987448","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23898080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W216444299","https://openalex.org/W1485904813","https://openalex.org/W1566305484","https://openalex.org/W1966298605","https://openalex.org/W1967725310","https://openalex.org/W1975246190","https://openalex.org/W1981382912","https://openalex.org/W1985302263","https://openalex.org/W1992523472","https://openalex.org/W1997486332","https://openalex.org/W1998253936","https://openalex.org/W2000252737","https://openalex.org/W2003615640","https://openalex.org/W2019711560","https://openalex.org/W2031019010","https://openalex.org/W2052875172","https://openalex.org/W2087366222","https://openalex.org/W2097792939","https://openalex.org/W2099079381","https://openalex.org/W2116844293","https://openalex.org/W2122412604","https://openalex.org/W2134542375","https://openalex.org/W2143428408","https://openalex.org/W2144002245","https://openalex.org/W2145028653","https://openalex.org/W2160271308","https://openalex.org/W2165114168","https://openalex.org/W2318443590","https://openalex.org/W2319384452","https://openalex.org/W4313347901"],"related_works":["https://openalex.org/W2331457028","https://openalex.org/W4403498356","https://openalex.org/W1924497726","https://openalex.org/W4408347498","https://openalex.org/W2968291860","https://openalex.org/W4410733361","https://openalex.org/W2014439685","https://openalex.org/W3125418198","https://openalex.org/W4407306684","https://openalex.org/W1985036347"],"abstract_inverted_index":{"BACKGROUND:":[0],"Melanoma":[1],"is":[2],"characterized":[3],"by":[4,54,107],"high":[5],"resistance":[6],"to":[7,15,40,71],"chemotherapy.":[8],"The":[9,43],"aim":[10],"of":[11,19,89,96,112,132,156,161,175],"this":[12,176],"study":[13],"was":[14,105,154],"investigate":[16],"combined":[17,165],"effects":[18,160],"doxorubicin":[20,162],"and":[21,35,46,62,79,92,114,121,130,136,145,152],"parthenolide":[22,146,153],"on":[23,141],"melanoma":[24,90],"cells.":[25],"MATERIALS":[26],"AND":[27],"METHODS:":[28],"Thiazolyl":[29],"blue":[30],"tetrazolium":[31],"bromide":[32],"(MTT)":[33],"assay":[34,60],"flow":[36],"cytometry":[37],"were":[38,52,69],"used":[39,70],"evaluate":[41,72],"viability.":[42],"p53":[44,113],"levels":[45],"Poly-ADP":[47],"ribose":[48],"polymerase":[49,65],"(PARP)":[50],"cleavage":[51],"assessed":[53],"western":[55],"blot.":[56],"Electrophoretic":[57],"mobility":[58],"shift":[59],"(EMSA)":[61],"quantitative":[63],"real-time":[64],"chain":[66],"reaction":[67],"(qRT-PCR)":[68],"changes":[73],"in":[74,150,163,172],"nuclear":[75,128],"factor-\u03baB":[76],"(NF-\u03baB)":[77],"activity":[78,111,124],"gene":[80],"expression,":[81],"respectively.":[82],"RESULTS:":[83],"Both":[84],"drugs":[85],"reduced":[86,118],"the":[87,97,119,127,164],"viability":[88],"cells":[91],"induced":[93,110],"apoptosis.":[94],"Expression":[95],"ATP-binding":[98],"cassette":[99],"sub-family":[100],"B":[101],"member-5":[102],"(ABCB5)":[103],"transporter":[104],"enhanced":[106],"doxorubicin.":[108],"Doxorubicin":[109,144],"NF-\u03baB.":[115],"Parthenolide":[116],"markedly":[117],"constitutive":[120],"doxorubicin-induced":[122],"NF-\u03baB":[123],"measured":[125],"as":[126],"NF-\u03baB,":[129],"expression":[131],"matrix":[133],"metalloproteinase-9":[134],"(MMP9)":[135],"it":[137],"had":[138],"no":[139],"effect":[140],"p53.":[142],"DISCUSSION:":[143],"affected":[147],"distinct":[148],"pathways":[149],"melanoma,":[151],"capable":[155],"combating":[157],"some":[158],"pro-survival":[159],"treatment.":[166],"This":[167],"provides":[168],"a":[169],"rationale":[170],"for":[171],"vivo":[173],"investigation":[174],"drug":[177],"combination.":[178]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}